Clinical trial
Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable…
NCT00343395 · Intermountain Health Care, Inc., Other · Terminated
Key facts
| NCT number | NCT00343395 |
|---|---|
| Title | Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study |
| Official title | A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Combined Rosiglitazone/Metformin (Avandamet®) vs. Placebo on Serological Outcomes in Non-Diabetic Patients With Stable Coronary Syndromes |
| Lead sponsor | Intermountain Health Care, Inc., Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | AVANDAMET |
| Enrollment | 200 |
| Start date | Jun 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Jun 23, 2006 |
| Last update posted | Mar 17, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: